Young researchers receive boost to develop innovative treatment for melanoma

Young researchers receive boost to develop innovative treatment for melanoma

4 March 2021

Melanoma research has received a boost with two researchers from Melanoma Institute Australia (MIA) and The University of Sydney awarded highly competitive fellowships from Cancer Institute NSW.

Dr Tuba Nur Gide and Dr Camelia Quek were each awarded an Early Career Fellowship to support their innovative research into melanoma treatment. The Fellowships are designed to encourage promising early career researchers who recently completed their PhD to choose cancer as their selected field of research endeavor.

“It is deeply rewarding to see these two talented young researchers receive these prestigious Fellowships,” said Prof Richard Scolyer, Co-Medical Director of MIA. “Their dedication and passion for developing more effective treatments for patients is inspiring and we are proud to have them as part of our team.”

While immunotherapy is proving effective in treating many advanced melanoma patients, others either don’t respond or develop resistance. These treatments can also cause significant, life-altering side-effects. Dr Nur Guide and Dr Quek are trying to identify which patients will respond to treatment and why, as this is essential to improving survival and quality of life for advanced melanoma patients around the world.

Prof Georgina Long AO, Co-Medical Director of MIA, is delighted that Dr Nur Guide and Dr Quek have received funding to pursue their research endeavors.

“Supporting medical research into Australia’s national cancer is vital to improving care for melanoma patients,” commented Prof Long. “With Australia at the forefront of global melanoma research efforts, it is exciting that our early career researchers will have the support they need to pioneer new treatments to improve the lives of melanoma patients.”

Personalised immunotherapy

There are currently no effective tests to determine which patients will respond to immunotherapy and which will need another treatment to stop their melanoma progressing. Dr Nur Gide’s research project is investigating this by assessing the accuracy of a panel of predictive tests with the aim of taking this out of the lab and into the everyday clinic setting.

“Once a patient enters a clinic, in real time we will be able to determine if they are likely to respond to treatment,” said Dr Nur Gide. “This will allow patients to avoid unnecessary toxicities and limit costs to patients and the healthcare system, as well as ultimately improving survival outcomes.”

The research project will help change the way cancer patients are treated and selected for clinical trials, by moving away from the one-size-fits-all approach and towards a precision approach to delivering effective immunotherapies on a personal basis.

“It is a great honour to have been awarded the CINSW Early Career Fellowship,” said Dr Nur Gide. “It will allow me to continue conducting research that will positively impact the lives of patients with advanced cancer and contribute to achieving our goal of zero deaths from melanoma.”

Understanding resistance to immunotherapy

Dr Camelia Quek’s research is trying to understand why some people with advanced melanoma become resistant to immunotherapy after they receive treatment. She is investigating the relatively new concept that a tumour and the microenvironment around it can evolve, causing resistance to immunotherapy. She will be using innovative computational biology methods to identify which genes and proteins involved in immune control are altered.

“Ultimately my research will provide significant benefits in developing innovative drug combination strategies and novel therapeutic targets to improve treatment for melanoma patients,” commented Dr Quek. “This will improve survival for patients, as well as improve their quality of life.”

“This fellowship will provide a fantastic opportunity for me to continue making discoveries that enable the development of innovative treatment strategies and biomarkers, ensuring the prolonged survival of Australians with cancer,” she said.

 

New research which more accurately predicts survival for melanoma patients
19 Apr 2017

New research which more accurately predicts survival for melanoma patients

Using MIA's patient database, researchers have developed conditional survival estimates for Stage III melanoma patients to more accurately predict survival outcomes.

Celebrating 60 years of melanoma research to save lives
19 Apr 2017

Celebrating 60 Years of melanoma research to save lives

MIA is proud to be celebrating an important milestone – the 60th anniversary of melanoma research and Australian-led global efforts to find a cure.

Celebrating our research achievements
07 Apr 2017

Celebrating our research achievements

Research achievements by MIA were celebrated at the annual Sydney Medical School recently.

Global Melanoma Research Report - April
06 Apr 2017

Global Melanoma Research Report - April

In this Global Research Report we showcase advances in medical oncology, reveal unexpected pathology in acral and skin melanoma, and uncover biomarkers and new gene targets for melanoma.

The people behind the Professors
29 Mar 2017

The people behind the Professors

Professor’s Long and Scolyer are well known in the academic community and beloved by their patients. But we wanted to get to know our new Conjoint Medical Directors a little more and hear their plans on making an impact on melanoma.

Wyong Rugby Leagues kicks goal to help end melanoma
28 Mar 2017

Wyong Rugby Leagues kicks goal to help end melanoma

Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.

Melanoma research reaches a milestone
21 Mar 2017

Melanoma research reaches a milestone

Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank. 

Contributing to the promise of Surgical Oncology
17 Mar 2017

Contributing to the promise of Surgical Oncology

MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.

Introducing Melanoma Institute Australia's Conjoint Medical Directors
14 Mar 2017

Introducing Melanoma Institute Australia's Conjoint Medical Directors

Two of the world’s best minds in melanoma have taken over the academic and clinical leadership of Melanoma Institute Australia (MIA). Professor Georgina Long and Professor Richard Scolyer are the new Conjoint Medical Directors of MIA, and are shaping the future direction of melanoma research, treatment and education.

A day in the life of... Georgia Cairns CNC
10 Mar 2017

A day in the life of... Georgia Cairns CNC

Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.

The real tragedy on Married At First Sight that Australia should be talking about....
08 Mar 2017

The real tragedy on Married At First Sight that Australia should be talking about....

Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.

Melanoma Institute Australia celebrates International Women's Day
08 Mar 2017

Melanoma Institute Australia celebrates International Women's Day

To celebrate International Women's Day 2017, MIA shares how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.

New Chairman of the Board for Melanoma Institute Australia
01 Mar 2017

New Chairman of the Board for Melanoma Institute Australia

We welcome Mr Grant King to the position of Chairman of the Board of Melanoma Institute Australia, following the retirement of Mr Reg Richardson AM who led the organisation for 10 years.

MIA student honoured with NSW National Council of Women Australia Day Award
10 Feb 2017

MIA student honoured with NSW National Council of Women Australia Day Award

Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work. 

Melanoma Institute Australia joins forces with Wollongong Wolves in the fight against melanoma
06 Feb 2017

Melanoma Institute Australia joins forces with Wollongong Wolves in the fight against melanoma

Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.

 

Follow-up scans after surgery for melanoma
25 Jan 2017

Follow-up scans after surgery for melanoma

A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.

Sunscreen tips for a skin smart summer!
25 Jan 2017

Sunscreen tips for a skin smart summer!

Sunscreen tips for a skin smart summer with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.

Improving survival in uveal melanoma
11 Jan 2017

Improving survival in uveal melanoma

Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.

Melanoma patient, Lucinda Ryan taking on melanoma one step at a time
21 Dec 2016

Melanoma prevention and awareness on 720 ABC Perth

Lucinda Ryan and Carole Renouf talking about melanoma preventation and awareness on 720 ABC Perth.

Melanoma research gets a funding boost from NHMRC
09 Dec 2016

Melanoma research gets a funding boost from NHMRC

Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.